OKYO Pharma OKYO
NASDAQ OKYO
$1.47 +0.15 (+11.36%)
At close: Oct 2, 2026 · 4:00 PM EDT

OKYO Pharma (OKYO) Depreciation and Depletion (2023 - 2026)

Updated

OKYO Pharma's Depreciation and Depletion came in at -$743 million for the quarter ended Mar 31, 2026.

Analysis

OKYO Pharma (OKYO) Depreciation and Depletion (2023 - 2026) Analysis & Trends

For the year ended Mar 31, 2026, OKYO Pharma's Depreciation and Depletion was $1.82 billion, down 29.0% from the prior year.

  • Depreciation and Depletion carries a five-year compound annual growth rate of -1.6% (years ended Mar 2021 to Mar 2026).
  • Going back by year, Depreciation and Depletion was $2.56 billion in the year ended Mar 31, 2025, $3.87 billion in the year ended Dec 31, 2024 (+1.8%), $3.8 billion in the year ended Dec 31, 2023 and $3.19 billion in the year ended Mar 31, 2022 (+61.3%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 194.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 98.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 OKYO Pharma 901.51 Mn 901.51 Mn - -743.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -743.00 Mn
Dec 31, 2025 2.56 Bn
Sep 30, 2023 -2,995.00
API Access

OKYO Pharma Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=OKYO&period=max&api_key=YOUR_API_KEY